SXTP
60 Degrees Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.92
−1.16%Margins
Gross margin
19.4%
EBITDA margin
-726.0%
EBIT margin
-774.9%
Net margin
-730.2%
FCF margin
-805.6%
-310.3%
Return on equity
-189.4%
Return on assets
-311.3%
Return on invested capital
0.20x
Asset turnover
-$8.8M
Cash from operations
$0.29
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026